Cargando…

Acute Pancreatitis Following Brentuximab Vedotin Therapy for Refractory Hodgkin Lymphoma: A Case Report

Detalles Bibliográficos
Autores principales: Urru, S. A. M., Mariotti, E., Carta, P., Massidda, S., Marcias, M., Murru, R., Sanna, P., Angelucci, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964296/
https://www.ncbi.nlm.nih.gov/pubmed/24493291
http://dx.doi.org/10.1007/s40268-014-0036-x
_version_ 1782308624254631936
author Urru, S. A. M.
Mariotti, E.
Carta, P.
Massidda, S.
Marcias, M.
Murru, R.
Sanna, P.
Angelucci, E.
author_facet Urru, S. A. M.
Mariotti, E.
Carta, P.
Massidda, S.
Marcias, M.
Murru, R.
Sanna, P.
Angelucci, E.
author_sort Urru, S. A. M.
collection PubMed
description
format Online
Article
Text
id pubmed-3964296
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-39642962014-03-25 Acute Pancreatitis Following Brentuximab Vedotin Therapy for Refractory Hodgkin Lymphoma: A Case Report Urru, S. A. M. Mariotti, E. Carta, P. Massidda, S. Marcias, M. Murru, R. Sanna, P. Angelucci, E. Drugs R D Short Communication Springer International Publishing 2014-02-04 2014-03 /pmc/articles/PMC3964296/ /pubmed/24493291 http://dx.doi.org/10.1007/s40268-014-0036-x Text en © The Author(s) 2014 https://creativecommons.org/licenses/by-nc/2.5/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Short Communication
Urru, S. A. M.
Mariotti, E.
Carta, P.
Massidda, S.
Marcias, M.
Murru, R.
Sanna, P.
Angelucci, E.
Acute Pancreatitis Following Brentuximab Vedotin Therapy for Refractory Hodgkin Lymphoma: A Case Report
title Acute Pancreatitis Following Brentuximab Vedotin Therapy for Refractory Hodgkin Lymphoma: A Case Report
title_full Acute Pancreatitis Following Brentuximab Vedotin Therapy for Refractory Hodgkin Lymphoma: A Case Report
title_fullStr Acute Pancreatitis Following Brentuximab Vedotin Therapy for Refractory Hodgkin Lymphoma: A Case Report
title_full_unstemmed Acute Pancreatitis Following Brentuximab Vedotin Therapy for Refractory Hodgkin Lymphoma: A Case Report
title_short Acute Pancreatitis Following Brentuximab Vedotin Therapy for Refractory Hodgkin Lymphoma: A Case Report
title_sort acute pancreatitis following brentuximab vedotin therapy for refractory hodgkin lymphoma: a case report
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964296/
https://www.ncbi.nlm.nih.gov/pubmed/24493291
http://dx.doi.org/10.1007/s40268-014-0036-x
work_keys_str_mv AT urrusam acutepancreatitisfollowingbrentuximabvedotintherapyforrefractoryhodgkinlymphomaacasereport
AT mariottie acutepancreatitisfollowingbrentuximabvedotintherapyforrefractoryhodgkinlymphomaacasereport
AT cartap acutepancreatitisfollowingbrentuximabvedotintherapyforrefractoryhodgkinlymphomaacasereport
AT massiddas acutepancreatitisfollowingbrentuximabvedotintherapyforrefractoryhodgkinlymphomaacasereport
AT marciasm acutepancreatitisfollowingbrentuximabvedotintherapyforrefractoryhodgkinlymphomaacasereport
AT murrur acutepancreatitisfollowingbrentuximabvedotintherapyforrefractoryhodgkinlymphomaacasereport
AT sannap acutepancreatitisfollowingbrentuximabvedotintherapyforrefractoryhodgkinlymphomaacasereport
AT angeluccie acutepancreatitisfollowingbrentuximabvedotintherapyforrefractoryhodgkinlymphomaacasereport